UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The cognitive effect of anticholinergics for patients with overactive bladder

Welk, B; Richardson, K; Panicker, JN; (2021) The cognitive effect of anticholinergics for patients with overactive bladder. Nature Reviews Urology , 18 pp. 686-700. 10.1038/s41585-021-00504-x. Green open access

[thumbnail of Panicker_The cognitive effect of anticholinergics for patients with overactive bladder_AAM.pdf]
Preview
Text
Panicker_The cognitive effect of anticholinergics for patients with overactive bladder_AAM.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Overactive bladder (OAB) is often treated with medications that block the cholinergic receptors in the bladder (known as anticholinergics). The effect of this medication class on cognition and risk of dementia has been increasingly studied over the past 40 years after initial studies suggested that the anticholinergic medication class could affect memory. Short-term randomized clinical trials demonstrated that the administration of the anticholinergic oxybutynin leads to impaired memory and attention, and large, population-based studies showed associations between several different anticholinergic medications and dementia. However, trials involving anticholinergics other than oxybutynin have not shown such substantial effects on short-term cognitive function. This discordance in results between short-term cognitive safety of OAB anticholinergics and the long-term increased dementia risk could be explained by the high proportion of patients using oxybutynin in the OAB subgroups of the dementia studies, or a study duration that was too short in the prospective clinical trials on cognition with other OAB anticholinergics. Notably, all studies must be interpreted in the context of potential confounding factors, such as when prodromal urinary symptoms associated with the early stages of dementia lead to an increase in OAB medication use, rather than the use of OAB medication causing dementia. In patients with potential risk factors for cognitive impairment, the cautious use of selected OAB anticholinergic agents with favourable physicochemical and pharmacokinetic properties and clinical trial evidence of cognitive safety might be appropriate.

Type: Article
Title: The cognitive effect of anticholinergics for patients with overactive bladder
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41585-021-00504-x
Publisher version: https://doi.org/10.1038/s41585-021-00504-x
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: Bladder, Neurological disorders
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10137001
Downloads since deposit
90Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item